Four leading cancer research organizations in the United States and Canada announce the opening of patient enrollment to myeloMATCH, a unique portfolio of clinical trials to test precision medicine ...

Myelodysplastic syndromes (MDS) are blood cancers that reduce healthy blood cell production, leading to anemia, bleeding, fatigue, and frequent infections. Treatments target the affected blood counts, ...

Results from a retrospective study compared and explored biomarkers associated with outcomes in myelodysplastic syndrome (MDS) with plasma cell neoplasms. MDS is a group of heterogeneous clonal ...

“This study has been a personal quest,” said Mikkael Sekeres, M.D., chief of hematology at Sylvester Comprehensive Cancer Center. “I see veterans who develop these conditions and need expensive ...

Outpatient care for MDS patients can improve mental health and quality of life, reducing caregiver strain and hospital stays. Celiac disease is associated with increased risks for various cancers, ...

Evidence in real-world settings for multiple primary malignancies in prostate cancer: Comparison with single primary prostate cancers. Is increase in CME consumption associated with practice change in ...

An expert discussed the findings of the COMMANDS trial evaluating Reblozyl’s role in red blood cell transfusion independence for patients with MDS. Reblozyl (luspatercept) has become the new standard ...

A new study has identified taurine, which is made naturally in the body and consumed through some foods, as a key regulator of myeloid cancers such as leukemia. The paper is published in Nature. The ...